{"result": "Xigris, the brand name for drotrecogin alfa (activated), was a drug used in the treatment of septic shock. It was the commercial form of drotrecogin alfa (activated) available on the market. However, Xigris was withdrawn from the market in October 2011. This withdrawal was due to concerns over its efficacy and safety, leading to its discontinuation. The decision to withdraw Xigris was consistent across all descriptions, highlighting its removal from the market in 2011 after being identified as a treatment option for septic shock.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"XIGRIS\"\nDescription List: [\"Brand name for drotrecogin alfa (activated), withdrawn from the market in 2011\", \"Commercial form of drotrecogin alfa (activated) that was withdrawn from the market\\\"\", \"The market name for drotrecogin alfa (activated), which was withdrawn from the market in October 2011\", \"The market name for drotrecogin alfa (activated), which was withdrawn in 2011\", \"Xigris, a drug used in the treatment of septic shock, was withdrawn from the market in 2011\"]\n#######\nOutput:\n", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": 1}, "history": null}